1372629-20-3

Upstream product

• 2880-93-5 1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-5-iodo-4-methoxypyrimidin-2(1H)-one 
• 38953-75-2 (2R,3R,4R,5R)-2-((benzoyloxy)methyl)-5-(5-iodo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl dibenzoate 
• 1372629-19-0 2',3',5'-tri-O-benzoyl-5-(propyn-1-yl)uridine 
• 1372629-21-4 1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-5-(propyn-1-yl)-4-(1,2,4-triazol-1-yl)pyrimidin-2(3H)-one 
• 1372629-16-7 1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-5-iodo-4-(1,2,4-triazol-1-yl)pyrimidin-2(1H)-one 

Relevant academic research and scientific papers

Autofluorescent fused-pyrimidine nucleosides: Synthesis and evaluation as permeants and inhibitors of human nucleoside transporters

Nucleosides with an aromatic five-membered ring heterocycle (N, O, or S) fused at C4-C5 of pyrimidin-2-one were prepared by ring closures with 5-(alkyn-1-yl)pyrimidin-2-one intermediates, heterocyclic atom replacements, and ring closure with a 5-aminocyti